The acquisition of MS Bio, MJ Reider, and NorthEast BioLab, expands Normec’s expertise across food safety, water quality, and biopharmaceutical testing in one of the world’s largest TICC markets.

U.S.A. – Normec, a European testing, inspection, certification, and compliance (TICC) services provider, has entered the US market with three specialized acquisitions in foodcare, water quality and healthcare sectors.
The acquired US companies include Champaign, Ill.-based MS Bio, Philadelphia-based MJ Reider, and Hamden, Conn.-based NorthEast BioLab.
Founded in 2018, MS Bio is a nutrition supplement-focused testing laboratory serving manufacturers and producers in the dietary supplement, functional food, and cosmetics industries, with capabilities in microbiological and other analytical testing.
MJ Reider was established in 1952 as a full-service water testing laboratory. It offers comprehensive analyses across microbiology, inorganic and organic compounds, per- and polyfluoroalkyl substances (PFAS), and dioxins.
Joep Bruins, CEO of Normec, said, “The addition of MS Bio and MJ Reider not only strengthens our foodcare portfolio but also provides us with a robust platform to support manufacturers in navigating the complex regulatory landscape of food safety. Our goal is to deliver best-in-class compliance services that ensure product integrity and consumer trust.”
In addition to expanding its presence in the food and water sectors, Normec has also bolstered its healthcare and bioanalysis capabilities through the acquisition of NorthEast BioLab.
Founded in 2003, the Clinical Laboratory Improvement Amendments-certified bioanalytical laboratory serves the biopharmaceutical sector across all stages of drug development, from discovery through clinical trials. Its client base includes biotech firms, pharmaceutical companies, research institutions, and contract research organizations.
Joep Bruins also stated that the firm sees significant potential for both organic and inorganic growth in the United States and internationally as it continues to execute its growth strategy.
“Today’s announcement marks a pivotal moment in Normec’s journey and more than doubles our addressable market. With a Group valuation now exceeding €2 billion [US$2.3 billion], the addition of these three businesses, each known for deep technical expertise, customer trust, and unwavering commitment to quality, provides a strong foothold in the world’s largest TICC market,” he added.
With the specialized capabilities of these three laboratories, Normec strengthens its expertise across bioanalysis, water quality, and nutritional testing.
The acquisitions expand the group’s reach to serve clients across Europe and North America, enhancing its position as an international TICC platform with capabilities in four highly regulated and fast-growing sectors: food, life safety, sustainability, and healthcare.
The global TICC industry is valued at more than €200 billion (approximately US$232 billion), with the US representing one of its largest markets.
Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.